ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
Dow Jones
38.686,32
1,51%
Euro vs US Dollar
1,08565
0,00%
Bitcoin
67.719,11
-0,01%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. United Therapeutics Corporation (UTHR)

  7. United Therapeutics Corporation (UTHR) News

UTHR

United Therapeutics (UTHR)

United Therapeutics Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:UTHR
DatumZeitQuelleÜberschriftSymbolFirma
31/05/202413h00Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:UTHRUnited Therapeutics Corporation
30/05/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
28/05/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
22/05/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
20/05/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
16/05/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
16/05/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
16/05/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
14/05/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
14/05/202422h10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
10/05/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
08/05/202422h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
07/05/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
07/05/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
06/05/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
06/05/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
06/05/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
01/05/202412h30Business WireUnited Therapeutics Corporation Reports First Quarter 2024 Financial ResultsNASDAQ:UTHRUnited Therapeutics Corporation
26/04/202420h02Business WireCORRECTING and REPLACING PHOTO United Therapeutics Announces World’s First Successful Xenothymokidney TransplantNASDAQ:UTHRUnited Therapeutics Corporation
24/04/202415h00Business WireUnited Therapeutics Announces World’s First Successful Xenothymokidney TransplantNASDAQ:UTHRUnited Therapeutics Corporation
24/04/202413h00Business WireUnited Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024NASDAQ:UTHRUnited Therapeutics Corporation
16/04/202413h00Business WireUnited Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International ConferenceNASDAQ:UTHRUnited Therapeutics Corporation
26/03/202412h00Business WireUnited Therapeutics Announces the First Comprehensive Review Publication on XenotransplantationNASDAQ:UTHRUnited Therapeutics Corporation
25/03/202412h00Business WireUnited Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase ProgramNASDAQ:UTHRUnited Therapeutics Corporation
11/03/202421h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
11/03/202421h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
11/03/202421h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
07/03/202422h52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
07/03/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
07/03/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
 Showing the most relevant articles for your search:NASDAQ:UTHR

Kürzlich von Ihnen besucht

DBI
MDAX
MDAX
FX
EURUSD
Euro vs US Dollar
COIN
BTCUSD
Bitcoin
USOTC
BNPQY
BNP Paribas (QX)
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
TSLA
Tesla
AMEX
XLE
Energy Select Sector SPDR
NYSE
MCD
McDonalds
FX
EURGBP
Euro vs Sterling
TG
CBK
Commerzbank
COIN
ETHUSD
Ethereum
NYSE
XOM
Exxon Mobil
NASDAQ
AMZN
Amazon.com
NYSE
NKE
Nike
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten